NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors

Clinical trial NCT05583201 · UNKNOWN

Trial details

NCT number: NCT05583201
Sponsor: jianming xu
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Gastric Cancer Pancreatic Cancer Solid Tumor

Start date: 2022-10-13
Primary completion: 2024-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.